From detection to intervention : beta-cell biomarkers and immune therapies in type 1 diabetes

Key Points

• The research aims to investigate the role of beta-cell biomarkers in detecting type 1 diabetes and the potential of immune therapies for intervention.
• Literature review on beta-cell biomarkers
• Analysis of current immune therapies
• Evaluation of intervention strategies for type 1 diabetes
• Identified key biomarkers for early detection of beta-cell dysfunction
• Highlighted promising immune therapies for treatment
• Suggests a potential framework for integrating biomarkers into clinical practice